Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Clinical Trial 23482

Salt Lake City, UT 84102

Study Summary:

Despite currently available treatments for dyslipidemia, many patients do not reach therapeutic LDL-C goals and others sustain major CV events, even while being treated with adequate doses of medication. LDL-C lowering by inhibiting the action of proprotein convertase subtilisin kexin type 9 (PCSK9) appears to be a promising new dyslipidemia treatment.

Qualified Participants Must:

• Be 18 years of age, or older
• Have an LDL (“bad cholesterol”) value between 70-100
• Have some form of cardiovascular risk or disease
• Be taking Lipitor, Zocor or Crestor for high cholesterol

Qualified Participants May Receive:

Receive $50.00 per visit
Study medications provided.
No cost to participate
No insurance needed
No change in your doctor
Completely voluntary, no obligation to continue.

Research Site Profile

View Clinic Profile

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.